IE
DRUG

Israel Englander’s Bright Minds Biosciences DRUG Stock Holding History

Israel Englander’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69M Buy
66,740
+13,908
+26% +$1.09M ﹤0.01% 3051
2026
Q1 		$3.86M Sell
52,832
-141,605
-73% -$11.4M ﹤0.01% 3231
2025
Q4 		$15.2M Buy
194,437
+117,756
+154% +$7.87M 0.01% 1828
2025
Q3 		$4.65M Sell
76,681
-34,690
-31% -$1.35M ﹤0.01% 3216
2025
Q2 		$2.91M Sell
111,371
-81,186
-42% -$2.43M ﹤0.01% 3533
2025
Q1 		$6.95M Buy
192,557
+152,178
+377% +$5.57M ﹤0.01% 2542
2024
Q4 		$1.45M Buy
+40,379
New +$1.42M ﹤0.01% 3886

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Israel Englander's DRUG Position: Q2 2026 in Review

Israel Englander increased its Bright Minds Biosciences (DRUG) stake by 26% in Q2 2026, buying an estimated $1.09M and bringing the position to 66,740 shares worth $4.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3051.

Israel Englander first reported a position in DRUG in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.2M in Q4 2025. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Israel Englander held 66,740 shares of Bright Minds Biosciences worth $4.69M as of Q2 2026.
  • Israel Englander bought 13,908 Bright Minds Biosciences shares in Q2 2026, an estimated $1.09M.
  • Bright Minds Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3051 holding.
  • Israel Englander first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Israel Englander's Bright Minds Biosciences position peaked at $15.2M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.